COVID-19 test kit CG 2062
for neutralizing antibodySARS-COV-2coronavirus

COVID-19 test kit - CG 2062 - Getein Biotech Inc. - for neutralizing antibody / SARS-COV-2 / coronavirus
COVID-19 test kit - CG 2062 - Getein Biotech Inc. - for neutralizing antibody / SARS-COV-2 / coronavirus
COVID-19 test kit - CG 2062 - Getein Biotech Inc. - for neutralizing antibody / SARS-COV-2 / coronavirus - image - 2
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
for neutralizing antibody
Micro-organism
SARS-COV-2, coronavirus
Sample type
serum, plasma, whole blood, laboratory
Analysis mode
lateral flow
Format
cassette
Result display time

15 min

Description

Getein One Step Test for SARS-CoV-2 Total Antibody/ Neutralizing Antibody (Colloidal Gold) is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus. Intended Use SARS-CoV-2 Neutralizing Antibody Rapid Test is intended for in vitro qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum, plasma, venous whole blood or fingertip blood. The SARS-CoV-2 neutralizing antibodies are protective antibody produced by the human body after inoculation with novel coronavirus vaccine or infection with novel coronavirus. The kit is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus, it can be used to evaluate the immune effect after vaccination or whether neutralizing antibodies are produced in human body after infection with novel coronavirus, it should not be used to diagnose acute SARS-CoV-2 infection. For professional use only. About SARS-CoV-2 Neutralizing Antibody Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with millions infected. The immune responses of human body to the severe COVID-19 have been well studied, and a number of antibody-based assays have been developed for serological studies. Moreover, the study of the neutralizing antibody that targets at a special structural protein of the SARS-CoV-2 is of interest. Infection by the SARS-CoV-2 or immunized by vaccine against SARS-CoV-2 will induce immune responses, such as the production of antibodies in the blood.

VIDEO

Catalogs

No catalogs are available for this product.

See all of Getein Biotech Inc.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.